Quotient Biodiagnostics Signs 36 Month Agreement With the Premier Healthcare Alliance to Supply Blood Bank Reagents to Its 2,600 Member Hospitals

Published: Aug 16, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today announced that it has entered into a 36 month supply agreement with Premier healthcare alliance. The agreement is effective November 1st, 2012 and includes Quotient’s complete range of blood bank reagents, including its recently launched ALBAcyte® line of reagent red blood cell products, at specially negotiated pricing and terms.

Back to news